Kimyrsa Prescribing & Dosing Schedule

Dosage & Administration Drug label Prior authorization Financial assistance Patient education People also ask

Kimyrsa(oritavancin)

Kimyrsa 1200 MG Injection

NO BOXED WARNING

Dosage & Administration

* There are two oritavancin products (KIMYRSA and ORBACTIV®, another oritavancin product) that have differences in dose strength, duration of infusion and preparation instructions, including reconstitution and dilution instructions and compatible diluents
* Administer 1,200 mg of KIMYRSA as a single dose by intravenous infusion over 1 hour.
* Carefully follow the recommended dosage and dose preparation instructions for KIMYRSA in the full prescribing information.

drug label

Kimyrsa Prescribing Information

Contact Medical Science Liaison

Report Adverse Event

prior authorization

Kimyrsa Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form

Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form

Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form

Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form

Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form

Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form

Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form

Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form

Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form

Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form

Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Benefits investigation

Kimyrsa Healthcare Provider Request Form

financial assistance

Kimyrsa Financial Assistance Options

Copay savings program

Kimyrsa Healthcare Provider Request Form

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

Kimyrsa Healthcare Provider Request Form

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and copays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Kimyrsa Patient Education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Kimyrsa FAQs

How is the dosage of Kimyrsa?Kimyrsa is available in 1 dosages, including 1,200 mg Injection

What does Kimyrsa treat?Kimyrsa treats Infectious Skin Diseases, Staphylococcal Infections and Streptococcal Infections

What is Kimyrsa made of?Kimyrsa contains oritavancin which is a Lipoglycopeptide Antibacterial

How Is Kimyrsa Administered?Kimyrsa is administered as a Injectable

What Are The Kimyrsa Mechanism Of Action?Kimyrsa mechanism of action is Cytochrome P450 2C19 Inhibitors, Cytochrome P450 2C9 Inhibitors, Cytochrome P450 2D6 Inducers or Cytochrome P450 3A4 Inducers

FAQ Data Source

Dosage & Administration

Dosage & Administration

drug label

Kimyrsa Prescribing Information

prior authorization

Kimyrsa Prior Authorization Resources

Most recent state uniform prior authorization forms

Benefits investigation

financial assistance

Kimyrsa Financial Assistance Options

Copay savings program

Foundation programs

patient education

Kimyrsa Patient Education

Patient toolkit

people also ask

Kimyrsa FAQs